www.fdanews.com/articles/148738-gsk-sells-australian-drugs-to-aspen-for-423-million

GSK Sells Australian Drugs to Aspen for $423 million

August 15, 2012

GlaxoSmithKline advanced its clear-out of non-core drugs on Wednesday with a deal to sell 25 older brands marketed in Australia to South Africa’s Aspen Pharmacare for $423 million.
Yahoo! News